161 related articles for article (PubMed ID: 34757982)
21. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
[TBL] [Abstract][Full Text] [Related]
22. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
[TBL] [Abstract][Full Text] [Related]
23. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
24. Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population.
Church AJ; Moustafa D; Pinches RS; Hawryluk EB; Schmidt BAR
Pediatr Dermatol; 2022 May; 39(3):409-419. PubMed ID: 35194848
[TBL] [Abstract][Full Text] [Related]
25. Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.
Sunshine JC; Kim D; Zhang B; Compres EV; Khan AU; Busam KJ; Gerami P
Am J Dermatopathol; 2020 Dec; 42(12):923-931. PubMed ID: 33289976
[TBL] [Abstract][Full Text] [Related]
26. [Morphological and genetic aspects of Spitz tumors].
Wiesner T; Kutzner H
Pathologe; 2015 Feb; 36(1):37-43, 45. PubMed ID: 25613920
[TBL] [Abstract][Full Text] [Related]
27. Spitz Nevus and Other Spitzoid Tumors in Children. Part 2: Cytogenetic and Molecular Features. Prognosis and Treatment.
Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):20-25. PubMed ID: 31739993
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
[TBL] [Abstract][Full Text] [Related]
29. Copy number variations and clinical outcome in atypical spitz tumors.
Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
[TBL] [Abstract][Full Text] [Related]
30. Spitzoid melanoma and micrometastases in two lymph node regions: a critical situation.
Navarini AA; Bauer J; Barysch MJ; Kempf W; Mihic-Probst D; Kerl K; Kamarashev J; Giovanoli P; Kolios AG; Bergstraesser E; Dummer R
Eur J Dermatol; 2011; 21(2):229-33. PubMed ID: 21489908
[TBL] [Abstract][Full Text] [Related]
31. Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up.
Gerami P; Busam K; Cochran A; Cook MG; Duncan LM; Elder DE; Fullen DR; Guitart J; LeBoit PE; Mihm MC; Prieto VG; Rabkin MS; Scolyer RA; Xu X; Yun SJ; Obregon R; Yazdan P; Cooper C; Weitner BB; Rademaker A; Barnhill RL
Am J Surg Pathol; 2014 Jul; 38(7):934-40. PubMed ID: 24618612
[TBL] [Abstract][Full Text] [Related]
32. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
33. A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms.
Hillen LM; Geybels MS; Spassova I; Becker JC; Gambichler T; Garmyn M; Zur Hausen A; van den Oord J; Winnepenninckx V
FEBS Open Bio; 2020 Jul; 10(7):1326-1341. PubMed ID: 32431053
[TBL] [Abstract][Full Text] [Related]
34. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
Busam KJ; Kutzner H; Cerroni L; Wiesner T
Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
[TBL] [Abstract][Full Text] [Related]
36. Lack of distinct molecular profile of Primary Dermal Melanoma.
Shaigany S; Tessier-Cloutier B; Busam KJ; Horst BA
Hum Pathol; 2020 Dec; 106():32-38. PubMed ID: 32946880
[TBL] [Abstract][Full Text] [Related]
37. The role of gene fusions in melanocytic neoplasms.
Quan VL; Panah E; Zhang B; Shi K; Mohan LS; Gerami P
J Cutan Pathol; 2019 Nov; 46(11):878-887. PubMed ID: 31152596
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.
Saraggi D; Salmaso R; Zamuner C; Munari G; Lanza C; Alaibac MS; Bassetto F; Rugge M; Montesco MC; Cerroni L; Fassan M
J Am Acad Dermatol; 2018 Oct; 79(4):728-735. PubMed ID: 29920315
[TBL] [Abstract][Full Text] [Related]
39. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
40. Spitzoid melanoma.
Kamino H
Clin Dermatol; 2009; 27(6):545-55. PubMed ID: 19880042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
